Contemporary Topics
in Scleroderma

Agenda

Activity Directors

• David R. Fernandez, MD, PhD
  Attending Physician
  Hospital for Special Surgery

• Allan Gibofsky, MD, JD, MACR, FACP, FCLM
  Attending Physician
  Hospital for Special Surgery
  Professor of Medicine
  Weill Cornell Medical College

• Kimberly Lakin, MD, MS
  Attending Physician
  Hospital for Special Surgery
  Assistant Professor of Medicine
  Weill Cornell Medical College

Guest Faculty

• Kerri Aronson, MD
  Assistant Attending Physician
  NewYork-Presbyterian Hospital
  Assistant Professor of Medicine
  Weill Cornell Medical College
  New York, NY
  

• Dinesh Khanna, MD, MSc
  Professor of Medicine and Director
  University of Michigan Scleroderma Program
  Ann Arbor, MI

• Elana Jaye Bernstein, MD
  Florence Irving Associate Professor of Medicine
  Columbia University Vagelos College of Physicians and Surgeons
  Associate Attending
  NewYork-Presbyterian Hospital
  New York, NY

• Laura Hummers, MD, ScM
  Associate Professor of Medicine
  Johns Hopkins University
  Co-Director
  Johns Hopkins Scleroderma Center
  Baltimore, MD

• Philip O. Katz, MD
  Attending Physician
  NewYork-Presbyterian Hospital
  Assistant Professor of Medicine
  Weill Cornell Medical College
  New York, NY

• David T. Majure, MD, MPH
  Medical Director, Heart Transplant Service
  Weill Cornell Medicine
  Assistant Attending Physician
  NewYork-Presbyterian Hospital
  Assistant Professor of Medicine
  Weill Cornell Medical College
  New York, NY

• Elizabeth R. Volkmann, MD, MS
  Director, UCLA Scleroderma Program
  Founder & Co-Director, UCLA Connective Tissue Disease-Related Interstitial Lung Disease Program
  UCLA Health
  Los Angeles, CA

HSS Faculty

• Aviva L. Wolff, EdD, OT, CHT
  Occupational Therapist
  
  
• Franck Barrat, PhD
  Michael R. Bloomberg Chair
  Senior Scientist
  Member, David Z. Rosensweig Center for Genomics Research
  Hospital for Special Surgery
  Professor of Microbiology and Immunology
  Weill Cornell Medical College
  Faculty of the Immunology & Microbial Pathogenesis Graduate Program
  Weill Cornell Medical College

• Robert N. Hotchkiss, MD
  Medical Director of Clinical Research
  Director of Research, Hand & Upper Extremity Service
  Director of Translational and External Initiatives Research
  Attending Orthopedic Surgeon
  Hospital for Special Surgery
  Associate Professor of Clinical Orthopaedic Surgery, Weill Cornell Medical College
  Associate Attending Orthopedic Surgeon, NewYork-Presbyterian Hospital

• Robert F. Spiera, MD
  Director, Scleroderma and Vasculitis Program
  Attending Rheumatologist
  Hospital for Special Surgery
  Professor of Medicine
  Weill Cornell Medical College
  Attending Physician
  NewYork-Presbyterian Hospital
  Weill Cornell Medical Center
  
  
• Jessica K. Gordon, MD
  Attending Physician
  Hospital for Special Surgery
  Associate Professor of Medicine
  Weill Cornell Medical College

Target Audience

This activity is targeted to rheumatologists, residents, and fellows.

Accreditation and Credit Designation

Hospital for Special Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Hospital for Special Surgery designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Objectives

Hospital for Special Surgery Continuing Education activities are intended to improve the quality of patient care and safety. At the conclusion of this course, the participant will be able to:

• Evaluate emerging therapies (cellular and non-cellular) for systemic sclerosis, including mechanisms, evidence from clinical trials, and patient selection criteria.
• Apply current best practices in diagnosing and managing ILD, gastrointestinal involvement, Raynaud’s phenomenon, and pulmonary hypertension in SSc, incorporating advanced imaging and evolving treatment algorithms.
• Differentiate scleroderma skin disease from mimics and implement evidence-based strategies for managing skin fibrosis and dermatologic complications.
• Collaborate in multidisciplinary management, including rheumatology, gastroenterology, pulmonology, cardiology, dermatology, orthopedics, and rehabilitation, to optimize outcomes for patients with systemic sclerosis.

Acknowledgements

Funding support for the 2026 Contemporary Topics in Scleroderma Course is pending.

For sponsorship inquiries, please contact Alena Competello, Director, Office of Education Development and Alumni Affairs, at competelloa@hss.edu.